Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from Arjo AB ( ($SE:ARJO.B) ).
Arjo has announced the release date for its Q2 2025 interim report, which will be issued on July 11, followed by a conference call hosted by interim President and CEO Niclas Sjöswärd and interim CFO Christofer Carlsson. This announcement is significant for stakeholders, including fund managers, analysts, and media, as it provides an opportunity to engage with the company’s leadership and gain insights into its financial performance and strategic direction.
The most recent analyst rating on ($SE:ARJO.B) stock is a Buy with a SEK49.00 price target. To see the full list of analyst forecasts on Arjo AB stock, see the SE:ARJO.B Stock Forecast page.
More about Arjo AB
Arjo is a company focused on empowering movement within healthcare environments, offering products and solutions that enhance patient handling, medical beds, personal hygiene, disinfection, diagnostics, and the prevention of pressure injuries and venous thromboembolism. With over 7,000 employees worldwide and more than 65 years of experience, Arjo is committed to improving outcomes for individuals facing mobility challenges.
Average Trading Volume: 892,285
Current Market Cap: SEK8.8B
For detailed information about ARJO.B stock, go to TipRanks’ Stock Analysis page.